132 related articles for article (PubMed ID: 21163404)
21. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall.
Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P
Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin expression in thymomas.
Yang WI; Yang KM; Hong SW; Kim KD
Yonsei Med J; 1998 Feb; 39(1):37-44. PubMed ID: 9529983
[TBL] [Abstract][Full Text] [Related]
23. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression].
Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N
Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691
[TBL] [Abstract][Full Text] [Related]
24. [Pattern of intermediate filaments in thymomas].
Dirsch OR; Odermatt BF; Scherrer C; Heitz PU
Verh Dtsch Ges Pathol; 1990; 74():424-8. PubMed ID: 1708630
[TBL] [Abstract][Full Text] [Related]
25. [B-cells in thymic epithelial tumors: phenotype, distribution and relation to the intramedullary B-cell population of the normal thymus].
Fend F; Kirchner T; Marx A; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1992; 76():253-5. PubMed ID: 1283270
[TBL] [Abstract][Full Text] [Related]
26. [Histogenic and functional markers of epithelial differentiation in thymomas and thymus carcinomas].
Kirchner T; Hoppe F; Marx A; Papadopoulos T; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1988; 72():349-53. PubMed ID: 3218357
[No Abstract] [Full Text] [Related]
27. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
[TBL] [Abstract][Full Text] [Related]
28. [Surgical therapy for patients with thymoma or thymic carcinoma; based on WHO classification].
Yoneda S; Matsuzoe D; Kawahara K; Shirakusa T
Kyobu Geka; 2002 Oct; 55(11):926-30. PubMed ID: 12391687
[TBL] [Abstract][Full Text] [Related]
29. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
30. Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases.
Pan CC; Chen WY; Chiang H
Am J Surg Pathol; 2001 Jan; 25(1):111-20. PubMed ID: 11145245
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma.
Marchevsky AM; Gupta R; McKenna RJ; Wick M; Moran C; Zakowski MF; Suster S
Cancer; 2008 Jun; 112(12):2780-8. PubMed ID: 18442102
[TBL] [Abstract][Full Text] [Related]
32. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma.
Moser B; Schiefer AI; Janik S; Marx A; Prosch H; Pohl W; Neudert B; Scharrer A; Klepetko W; Müllauer L
Am J Surg Pathol; 2015 Apr; 39(4):541-8. PubMed ID: 25517960
[TBL] [Abstract][Full Text] [Related]
33. Primary thymic carcinoma: a clinicopathological and immunohistochemical study.
Shimizu J; Hayashi Y; Morita K; Arano Y; Yoshida M; Oda M; Murakami S; Watanabe Y; Nonomura A
J Surg Oncol; 1994 Jul; 56(3):159-64. PubMed ID: 7518018
[TBL] [Abstract][Full Text] [Related]
34. Thymoma. A clinicopathologic study of 98 cases with special reference to three unusual cases.
Hofmann W; Möller P; Manke HG; Otto HF
Pathol Res Pract; 1985 Jan; 179(3):337-53. PubMed ID: 3983013
[TBL] [Abstract][Full Text] [Related]
35. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness.
Chen FF; Yan JJ; Jin YT; Su IJ
Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596
[TBL] [Abstract][Full Text] [Related]
36. Controversies regarding the pathology of thymomas.
Kornstein MJ
Pathol Annu; 1992; 27 Pt 2():1-15. PubMed ID: 1584624
[No Abstract] [Full Text] [Related]
37. Evaluation of prognostic features in thymic epithelial tumors.
Kirchner T; Schalke B; Marx A; Müller-Hermelink HK
Thymus; 1989; 14(1-3):195-203. PubMed ID: 2623740
[TBL] [Abstract][Full Text] [Related]
38. Cortical versus medullary thymomas.
Le Marc'Hadour F
Hum Pathol; 1989 Jul; 20(7):715-6. PubMed ID: 2472349
[No Abstract] [Full Text] [Related]
39. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
Kojika M; Ishii G; Yoshida J; Nishimura M; Hishida T; Ota SJ; Murata Y; Nagai K; Ochiai A
Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882
[TBL] [Abstract][Full Text] [Related]
40. Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions.
Tateyama H; Mizuno T; Tada T; Eimoto T; Hashimoto T; Masaoka A
Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):265-9. PubMed ID: 8099456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
